Cuzzocrea Salvatore, Mazzon Emanuela, Di Paola Rosanna, Genovese Tiziana, Serraino Ivana, Dugo Laura, Cuzzocrea Elisabetta, Fulia Francesco, Caputi Achille P, Salvemini Daniela
Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Italy.
Crit Care Med. 2004 Jan;32(1):157-67. doi: 10.1097/01.CCM.0000098859.67006.45.
Zymosan enhances formation of reactive oxygen species, which contributes to the pathophysiology of organ failure during nonseptic shock. Here we have investigated the effects of M40401, a new superoxide dismutase mimetic, on the organ failure associated with nonseptic shock caused by zymosan in rats.
Experimental study.
Laboratory.
Male Sprague-Dawley rats.
We investigated the effects of M40401 on the organ failure associated with nonseptic shock caused by zymosan (500 mg/kg, administered intraperitoneally as a suspension in saline) in rats.
Organ failure and systemic inflammation in rats were assessed 18 hrs after administration of zymosan and/or M40401 and were monitored for 12 days (for loss of body weight and mortality). Treatment of rats with M40401 (10 mg/kg intraperitoneally, 1 and 6 hrs after zymosan) attenuated the peritoneal exudation and the migration of polymorphonuclear cells caused by zymosan. M40401 administration also attenuated the lung and intestinal injury (histology) as well as the increase in myeloperoxidase activity and malondialdehyde concentrations caused by zymosan in lung and intestine. Immunohistochemical analysis for nitrotyrosine and for poly(adenosine 5'-diphosphate-ribose) revealed positive staining in lung and intestine from zymosan-treated rats. The degree of staining for nitrotyrosine and poly(adenosine 5'-diphosphate-ribose) was markedly reduced in tissue sections obtained from zymosan-treated rats administered with M40401.
This study provides the first evidence that M40401 attenuates the degree of zymosan-induced nonseptic shock in the rat.
酵母聚糖可增强活性氧的形成,这在非感染性休克期间器官衰竭的病理生理学过程中发挥作用。在此,我们研究了新型超氧化物歧化酶模拟物M40401对酵母聚糖所致大鼠非感染性休克相关器官衰竭的影响。
实验研究。
实验室。
雄性Sprague-Dawley大鼠。
我们研究了M40401对酵母聚糖(500 mg/kg,以生理盐水混悬液腹腔注射)所致大鼠非感染性休克相关器官衰竭的影响。
在给予酵母聚糖和/或M40401后18小时评估大鼠的器官衰竭和全身炎症反应,并持续监测12天(观察体重减轻和死亡率)。用M40401(10 mg/kg腹腔注射,在酵母聚糖注射后1小时和6小时)治疗大鼠,可减轻酵母聚糖所致的腹膜渗出和多形核细胞迁移。给予M40401还可减轻肺和肠道损伤(组织学)以及酵母聚糖所致肺和肠道中髓过氧化物酶活性增加和丙二醛浓度升高。对硝基酪氨酸和聚(腺苷5'-二磷酸核糖)的免疫组织化学分析显示,酵母聚糖处理的大鼠肺和肠道中有阳性染色。在给予M40401的酵母聚糖处理大鼠的组织切片中,硝基酪氨酸和聚(腺苷5'-二磷酸核糖)的染色程度明显降低。
本研究首次证明M40401可减轻酵母聚糖诱导的大鼠非感染性休克程度。